Ionix Logo Developing innovative technology for minimally-invasive treatments Ionix Splash Image
  • Patients
  • Physicians
  • Technology
  • About Us
  • Contact Us


Millions of men over the age of 50 are affected by urination problems due to benign prostatic hyperplasia (BPH).1 This condition causes symptoms that adversely affect quality of life.

To meet the needs of these men, Ionix Medical is developing the Neuflo BPH DC Ablation System. The Neuflo System is being developed as a minimally-invasive, office-based treatment for urinary symptoms due to the enlargement of the prostate. Precisely focused energy is used to ablate prostate tissue via a transurethral catheter which is intended to reduce the constriction of the urethra and relieve BPH symptoms. Learn More.

1 American Urological Association of Education and Research, Inc. Guideline on the Management of Benign Prostatic Hyperplasia (BPH), 2003.

Caution: Investigational device. Limited by Federal (US) law to investigational use.

© 2009 Ionix Medical, Inc. All rights reserved.